BioCentury
ARTICLE | Clinical News

Ampion: Phase III started

January 20, 2014 8:00 AM UTC

Ampio began the double-blind, placebo-controlled Phase III STEP trial to evaluate a single 4 mL intra-articular injection of Ampion in 500 patients with OA of the knee. The study is the second of 2 pi...